Citation:Verbeek RE, van Oijen MG, ten Kate FJ, Vleggaar FP, Schipper ME, Casparie MK, et al 2012

Citation

Verbeek RE, van Oijen MG, ten Kate FJ, Vleggaar FP, Schipper ME, Casparie MK, et al. Surveillance and follow-up strategies in patients with high-grade dysplasia in Barrett's esophagus: a Dutch population-based study. Am J Gastroenterol 2012 Apr 1;107(4):534-42 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/22270082.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Verbeek RE, van Oijen MG, ten Kate FJ, Vleggaar FP, Schipper ME, Casparie MK, et al 2012	What endoscopic surveillance protocol should be followed for patients with BO and high grade dysplasia?	Dr Mark Appleyard MD FRACP MRCP MBBS BSc	completed
Verbeek RE, van Oijen MG, ten Kate FJ, Vleggaar FP, Schipper ME, Casparie MK, et al 2012 2	What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?	Professor David Whiteman B Med Sci, MBBS (Hons) PhD FAFPHM	completed
Verbeek RE, van Oijen MG, ten Kate FJ, Vleggaar FP, Schipper ME, Casparie MK, et al 2012 3	Are there groups of patients with non-dysplastic BO that require more frequent surveillance?	Dr Henry To	completed
Verbeek RE, van Oijen MG, ten Kate FJ, Vleggaar FP, Schipper ME, Casparie MK, et al 2012 4	Are there groups of patients with BO that can be discharged from surveillance?	Conjoint Associate Professor Philip Craig	completed

Compare quality appraisals for each clinical question

• What endoscopic surveillance protocol should be followed for patients with BO and high grade dysplasia? (compare critical appraisals)
• What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma? (compare critical appraisals)
• Are there groups of patients with non-dysplastic BO that require more frequent surveillance? (compare critical appraisals)
• Are there groups of patients with BO that can be discharged from surveillance? (compare critical appraisals)

Cited by

1. Are there groups of patients with non-dysplastic BO that require more frequent surveillance?
2. What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?
3. What endoscopic surveillance protocol should be followed for patients with BO and high grade dysplasia?